Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Nov
2
2015
Health Subcommittee to Mark Up Seven Bills; HHS Waives Fraud and Abuse Laws in Shared Savings Program; Two-Midnight Rule Revisions Finalized Squire Patton Boggs (US) LLP
Oct
30
2015
Estoppel in Context of Inter Partes Review Proceedings McDermott Will & Emery
Oct
29
2015
Marijuana in the Workplace: The Growing Conflict Between Drug and Employment Laws Epstein Becker & Green, P.C.
Oct
29
2015
Court Orders Re-Trial of AseraCare Falsity Phase Based on Jury Instruction Errors McDermott Will & Emery
Oct
28
2015
Inferior Vena Cava (IVC) Claims Are on the Rise Stark & Stark
Oct
28
2015
Brazil: Federal District Court in Rio de Janeiro Declares AstraZeneca’s Patent Covering Fosladex Invalid Michael Best & Friedrich LLP
Oct
27
2015
Recent Reports Claim Improvements in FDA’s Review of Medical Device Submissions Covington & Burling LLP
Oct
26
2015
Meaty Issue: Do Red and Processed Meats Cause Cancer? ArentFox Schiff LLP
Oct
26
2015
President Announces Efforts to Target Prescription Drug Abuse and Heroin Epidemic Jackson Lewis P.C.
Oct
23
2015
FDA’s Office of Planning Issues Report on Review Process for Combination Products Covington & Burling LLP
Oct
23
2015
Australian Patent Office Proposes “Coding Only” Sequence Ban Schwegman, Lundberg & Woessner, P.A.
Oct
22
2015
Medical Cannabis in Illinois: What Employers Need to Know Much Shelist, P.C.
Oct
22
2015
FTC Takes No Action Re: Use of “Diet” in Zero Calorie Soft Drinks; FDA Still Reviewing Morgan, Lewis & Bockius LLP
Oct
20
2015
D.C. Federal Court Rejects HHS Interpretation of 340B Program’s Orphan Drug Rule McDermott Will & Emery
Oct
20
2015
The Federal Circuit Declines To Revisit Its Decision That The Biosimilars Patent Dance Is Optional – Next Stop, Supreme Court? Squire Patton Boggs (US) LLP
Oct
20
2015
D.C. District Court Vacates HRSA’s Interpretative Rule on Orphan Drugs Epstein Becker & Green, P.C.
Oct
19
2015
No Rehearing Of Biosimilar Patent Dance Decision Foley & Lardner LLP
Oct
19
2015
D.C. Court Strikes Down 340B Orphan Drug Rule Again: Will This Impact the “Mega Guidance”? Foley & Lardner LLP
Oct
19
2015
House To Vote On ACA Repeal Provisions; HHS Projects 2016 ACA Marketplace Enrollment; HRSA’s 340B Orphan Drug Policy Struck Down Again Squire Patton Boggs (US) LLP
Oct
19
2015
It’s Status Quo for Now: Federal Circuit Denies Petition for Rehearing En Banc in Amgen v. Sandoz Michael Best & Friedrich LLP
Oct
16
2015
China's New Food Safety Law Became Effective Oct. 1: Are You in Compliance? Keller and Heckman LLP
Oct
16
2015
China's New Food Safety Law is in Effect Keller and Heckman LLP
Oct
15
2015
FDA to Host First Public Meeting on Biotech Regulation Overhaul Mintz
Oct
13
2015
PTAB Institutes Kyle Bass Lialda Patent IPR Foley & Lardner LLP
Oct
12
2015
Next Rx: New Medicare Part D Initiative Advances Role of Medication Management in Reform Sheppard, Mullin, Richter & Hampton LLP
Oct
12
2015
FDA Releases First Wholesaler and 3PL Facility Licensure Data to the Public Mintz
Oct
9
2015
Vermont GMO Battle Continues in Second Circuit Armstrong Teasdale
Oct
8
2015
Medical Cannabis in Illinois: What Health Care Providers and Organizations Need to Know Much Shelist, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins